FDA issues Drug Safety Communication regarding an increased risk for fractures of the hip, wrist and spine associated with the use of PPIs.
2010 – FDA issues Drug Safety Communication
Announcement Date: May 25, 2010
FDA issues Drug Safety Communication regarding an increased risk for fractures of the hip, wrist and spine associated with the use of PPIs.